-
公开(公告)号:US20230357798A1
公开(公告)日:2023-11-09
申请号:US18029798
申请日:2021-10-12
CPC分类号: C12N15/907 , C12N9/22 , C12N15/11 , C12N15/111 , A61K35/28 , A61P37/00 , C12N2310/20 , C12N2310/321 , C12N2310/315 , C12N2320/34
摘要: The present disclosure provides methods and compositions for treating X-CGD in subjects, comprising genetically modifying cells from the subjects ex vivo by integrating a functional, codon-optimized CYBB cDNA at the endogenous CYBB locus.
-
公开(公告)号:US20240173355A1
公开(公告)日:2024-05-30
申请号:US18551975
申请日:2022-04-05
IPC分类号: A61K35/28 , A61K35/545 , A61P37/04 , C12N5/074 , C12N5/0789 , C12N9/22 , C12N15/11 , C12N15/86
CPC分类号: A61K35/28 , A61K35/545 , A61P37/04 , C12N5/0647 , C12N5/0696 , C12N9/22 , C12N15/111 , C12N15/86 , C12N2310/20 , C12N2750/14143
摘要: The present disclosure provides methods and compositions for treating RAG2 deficiencies in subjects, comprising genetically modifying cells from the subjects ex vivo by integrating a functional, codon-optimized RAG 2 cDNA at the endogenous RAG2 locus.
-
公开(公告)号:US20240093242A1
公开(公告)日:2024-03-21
申请号:US18007439
申请日:2021-08-03
IPC分类号: C12N15/90 , A61K35/28 , C12N5/0789 , C12N9/22 , C12N15/113
CPC分类号: C12N15/907 , A61K35/28 , C12N5/0647 , C12N9/22 , C12N15/1138 , C12N2310/20 , C12N2310/315 , C12N2310/344 , C12N2510/00 , C12N2800/80
摘要: The present disclosure provides methods and compositions for treating SCID-X1 in subjects, comprising genetically modifying cells from the subjects ex vivo by integrating a full-length, codon-optimized IL2RG cDNA at the endogenous IL2RG locus.
-
-